Trademark: LAMP 2147493
Word
LAMP
ID
2147493
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
04 August 2020
Registration Date
04 August 2020
Renewal Date
04 August 2030
Owner(s)
Service
Davies Collison Cave Pty Ltd
Goods and Services:
Class 5:
Therapeutic preparations; therapeutic preparations, namely, antibodies for use in targeting C-C chemokine receptor type [CCR5] cell receptor; therapeutic preparations for the prevention and treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, non alcoholic steatohepatitis.
Therapeutic preparations; therapeutic preparations, namely, antibodies for use in targeting C-C chemokine receptor type [CCR5] cell receptor; therapeutic preparations for the prevention and treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, non alcoholic steatohepatitis.
Class 42:
Scientific research consulting services; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, non alcoholic steatohepatitis; medical research and analysis services; medical research and analysis services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research and analysis services in the field of therapeutic agents, preparations and substances for the prevention and treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, non alcoholic steatohepatitis.
Scientific research consulting services; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, non alcoholic steatohepatitis; medical research and analysis services; medical research and analysis services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research and analysis services in the field of therapeutic agents, preparations and substances for the prevention and treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, non alcoholic steatohepatitis.
Class 44:
Providing health and medical information, namely, providing information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, non alcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19 via a website
Providing health and medical information, namely, providing information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, non alcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19 via a website